Sb Investment Advisers (Uk) LTD Relay Therapeutics, Inc. Transaction History
Sb Investment Advisers (Uk) LTD
- $12.1 Billion
- Q3 2024
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 27,904,963 shares of RLAY stock, worth $133 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
27,904,963
Previous 27,904,963
-0.0%
Holding current value
$133 Million
Previous $182 Million
8.59%
% of portfolio
1.63%
Previous 1.68%
Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
204Shares Held
156MCall Options Held
207KPut Options Held
40K-
Vanguard Group Inc Valley Forge, PA14.5MShares$68.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$50.1 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$43.9 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$35 Million0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY5.52MShares$26.2 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $571M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...